POSSIBLE INFLUENCE OF LOXOPROFEN IN LIPOPOLYSACCHARIDE INDUCED ALTERATIONS IN SUCROSE INTAKE IN CHRONIC MILD STRESS MODEL IN MICE

KUNDU SMITA S; DIGVIJAYSINH G RANA

doi:10.22159/ajpcr.2021.v14i7.41249

Authors

KUNDU SMITA S Department of Pharmacology, Babaria Institute of Pharmacy, Vadodara, Gujarat, India.
DIGVIJAYSINH G RANA Department of Pharmacology, Babaria Institute of Pharmacy, Vadodara, Gujarat, India.

DOI:

https://doi.org/10.22159/ajpcr.2021.v14i7.41249

Keywords:

Chronic mild stress, Depression, Lipopolysaccharide, Loxoprofen, Mice

Abstract

Objective: The objective of the present study was to evaluate the influence of Loxoprofen in sucrose intake in the absence and presence of Lipopolysaccharide in chronic mild stress model of depression in mice.

Methods: There was a measurement of sucrose intake in chronic mild stress model (CMS), consisting of 21 days stress schedule in which mice were subjected to the treatment of Loxoprofen (16.8 mg/kg, p.o.) with or without treatment of lipopolysaccharide (LPS) (0.5 mg/kg i.p.) for the past 14 days.

Results: The result of the present study indicated that mice treated with Venlafaxine and Loxoprofen showed a significant increase in the sucrose intake in stressed mice in chronic mild stress model. LPS-treated mice presented a decrease in sucrose intake when compared to controls. Similarly, Venlafaxine and Loxoprofen in the presence of LPS could increase the sucrose intake as compared to LPS treated stressed mice.

Conclusion: The results of the present study showed that Loxoprofen could influence LPS induced alterations in sucrose intake in mice in chronic mild stress model. It can also indicate the possible anti-depressant effect of Loxoprofen in mice subjected to chronic mild stress model of depression, having its possible implication in future treatment of depression.

Downloads

Download data is not yet available.

References

Simon GE. Social and economic burden of mood disorders. Biol Psychiatry 2003;54:208-15. DOI: https://doi.org/10.1016/S0006-3223(03)00420-7

Zajecka JM. Clinical issues in long-term treatment with antidepressants. J Clin Psychiatry 2000;61:20-5.

Patel A. The role of inflammation in depression. Psychiatr Danub 2013;25 Suppl 2:216-23.

Farooq RK, Asghar K, Kanwal S, Zulqernain A. Role of inflammatory cytokines in depression: Focus on interleukin-1β. Biomed Rep 2017;6:15-20. DOI: https://doi.org/10.3892/br.2016.807

Felger JC, Lotrich FE. Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implication. J Neurosci 2013;29:199-229. DOI: https://doi.org/10.1016/j.neuroscience.2013.04.060

Jangpangi D. Depression and inflammation: Pathophysiology and therapeutic implications. CHRISMED J Health Res 2016;3:155-60. DOI: https://doi.org/10.4103/2348-3334.183728

Noto C, Rizzo LB, Mansur RB, McIntyre RS, Maes M, Brietzke E. Targeting the inflammatory pathway as a therapeutic tool for major depression. Neuroimmunomodulation 2014;21:131-9. DOI: https://doi.org/10.1159/000356549

Lieb J, Karmali R, Horrobin DF. Elevated levels of PGE2, and the thromboxane B2 in depression. Prostaglandins Leukot Med 1983;10:361-7. DOI: https://doi.org/10.1016/0262-1746(83)90048-3

Calabrese JR, Skwerer RG, Barna B, Gulledge AD, Valenzuela R, Butkus A, et al. Depression, immunocompetence, and prostaglandins of the E series. Psychiatry Res 1986;17:41-7. DOI: https://doi.org/10.1016/0165-1781(86)90040-5

Linnoila M, Whorton AR, Rubinow DR, Cowdry RW, Ninan PT, Waters RM. CSF prostaglandin levels in depressed and schizophrenic patients. Arch Gen Psychiatry 1983;40:405-6. DOI: https://doi.org/10.1001/archpsyc.1983.01790040059008

Fritz M, Klawonn AM, Nilsson A, Singh AK, Lazarus M, Löfberg A, et al. Prostaglandin dependent modulation of dopaminergic neurotransmission elicits inflammation-induced aversion in mice. J Clin Invest 2016;126:695-705. DOI: https://doi.org/10.1172/JCI83844

Brenneis C, Coste O, Altenrath K, Angioni C, Schmidt H, Schuh CD, et al. Anti-inflammatory role of microsomal prostaglandin E synthase-1 in a model of neuroinflammation. J Biol Chem 2010;286:2331-42. DOI: https://doi.org/10.1074/jbc.M110.157362

Ohishi K, Ueno R, Nishino S, Sakai T, Hayaishi O. Increased level of salivary prostaglandins in patients with major depression. Biol Psychiatry 1988;23:326-34. DOI: https://doi.org/10.1016/0006-3223(88)90283-1

Nishino S, Ueno R, Ohishi K, Sakai T, Hayaishi O. Salivary prostaglandin concentrations: Possible state indicators for major depression. Am J Psychiatry 1989;146:365-8. DOI: https://doi.org/10.1176/ajp.146.3.365

De Paiva VN, Lima SN, Fernandes MM, Soncini R, Andrade CA, Giusti-Paiva A. Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice. Behav Brain Res 2010;215:146-51. DOI: https://doi.org/10.1016/j.bbr.2010.07.015

Li RC, Row BW, Gozal E, Kheirandish L, Fan Q, Brittian KR, et al. Cyclooxygenase 2 and intermittent hypoxia-induced spatial deficits in the rat. Am J Respir Crit Care Med 2003;168:469-75. DOI: https://doi.org/10.1164/rccm.200211-1264OC

Müller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein- Müller B, et al. The cyclo-oxygenase 2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double blind, randomized, placebo controlled, add on pilot study to reboxetine. Mol Psychiatry 2006;11:680-4. DOI: https://doi.org/10.1038/sj.mp.4001805

Teeling JL, Cunningham C, Newman TA, Perry VH. The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1. Brain Behav Immun 2010;24:409-19. DOI: https://doi.org/10.1016/j.bbi.2009.11.006

Lee RE. The influence of psychotropic drugs on prostaglandin biosynthesis. Prostaglandins 1974;5:63-8. DOI: https://doi.org/10.1016/S0090-6980(74)80132-2

Bekemeier H, Giessler AJ, Vogel E. Influence of MAO inhibitors, neuroleptics, morphine, mescaline, divascan, aconitine, and pyrogenes on prostaglandin biosynthesis. Pharmacol Res Comm 1977;9:587-98. DOI: https://doi.org/10.1016/S0031-6989(77)80087-8

Fjalland B. Influence of various substances on prostaglandin biosynthesis by guinea pig chopped lung. J Pharm Pharmacol 1976;28:683-9. DOI: https://doi.org/10.1111/j.2042-7158.1976.tb02836.x

Hong SL, Carty T, Deykin D. Tranylcypromine and 15-hydroperoxy arachidonate affect arachidonic acid release in addition to inhibition of prostaglandin synthesis in calf aortic endothelial cells. J Biol Chem 1980;255:9538-40. DOI: https://doi.org/10.1016/S0021-9258(18)43423-0

Mtabaji JP, Manku MS, Horrobin DF. Actions of the tricyclic anti depressant clomipramine on responses to pressor agents. Interactions with prostaglandin E2. Prostaglandins 1977;14:273-81. DOI: https://doi.org/10.1016/0090-6980(77)90161-7

Futaki N, Harada M, Sugimoto M, Hashimoto Y, Honma Y, Arai I, et al. The importance of brain PGE2 inhibition versus paw PGE2 inhibition as a mechanism for the separation of analgesic and antipyretic effects of Lornoxicam in rats with paw inflammation. J Pharm Pharmacol 2009;61:607-14. DOI: https://doi.org/10.1211/jpp.61.05.0009

Thomas J, Khanam R, Vohora D. Augmentation of effect of venlafaxine by folic acid in behavioral paradigms of depression in mice: Evidence of serotonergic and pro-inflammatory cytokine pathways. Pharmacol Rep 2016;68:396-403. DOI: https://doi.org/10.1016/j.pharep.2015.10.003

Mello BS, Monte AS, McIntyre RS, Soczynska JK, Custódio CS, Cordeiro RC, et al. Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration. J Psychiatr Res 2013;47:1521-9. DOI: https://doi.org/10.1016/j.jpsychires.2013.06.008

Chen Y, Wang HD, Xia X, Kung HF, Pan Y, Kong LD. Behavioural and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the chronic mild stress model of depression in mice. Phytomedicine 2007;14:523-9. DOI: https://doi.org/10.1016/j.phymed.2006.09.007

Abramsom LY, Seligmen ME. Modeling psychopathology in the laboratory: History and rationale. In: Maser JP, Seligman ME, editors, Psychopathology; Experimental Models. San Francisco: Freeman Inc.; 1978. p. 1-26.